Palladin, Cytoskeletal Associated Protein (PALLD) (N-Term) Peptide
Quick Overview for Palladin, Cytoskeletal Associated Protein (PALLD) (N-Term) Peptide (ABIN8107589)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- PALLD Peptide - N-terminal region
-
Sequence
- HQRKGGPQSQ LCDKAANLIE ELTSIFKAAK PRNRSPNGES SSPDSGYLSP
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-PALLD Antibody (ARP74111_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
-
Background
-
Background Information: This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.
Alternative Symbols: PALLD,KIAA0992,CGI-151,
-
Molecular Weight
- 152kDa
-
Gene ID
- 23022
-
NCBI Accession
- XP_005262919
-
UniProt
- Q8WX93
Target
-
